Oncology

Doxorubicin can be safely omitted in treatments for Wilms' tumor patients deemed least likely to relapse.

Targeting protein that helps cancer cells survive chemotherapy shows promise.

Protein may potentially offer a future therapeutic target.

Stopping smoking extends survival by nearly a year.

Treatment improves overall survival.

T cells derived from lymph nodes expanded and activated in a laboratory before being injected back into patients.

Protein AKAP4 identified as the most accurate way to detect non-small cell lung cancer.

Study finds that mitochondria of tumor cells are critical to survival and proliferation.

Pfizer executive discusses the present and future of biosimilars.

Drug could be less expensive to produce and less harmful to healthy cells.

Drug treats cutaneous manifestations of t-cell lymphoma.

Pazopanib shows promise in soft tissue sarcoma patients.

MM41 targets cell nuclei to provide a new method of attacking pancreatic cancer.

Nivolumab and ipilmumab help immune system to shrink tumors.

Restoration of miR-29 in cancer stromal cells helped decrease cancer growth.

Treatment could make existing cancer drugs more effective.

The impact of products such as orange juice on melanoma.

CEO of Avella Specialty Pharmacy Rebecca M. Shanahan, Esq., discusses how specialty pharmacies can best manage the rising cost of specialty drugs to improve outcomes for patients.

There are currently more than 600 trials of biosimilars ongoing.

Hormones that reduce side effects may stimulate growth of cells resistant to therapy.

Combination of immunotherapy and epigenetics put patients into remission, even after failing the standard treatment.

Drugs like Viagra previously thought to increase risk of malignant melanoma.

Size and speed of tumor growth similar in dogs and humans.

Small molecule agent able to detect or destroy prostate cancer cells when combined with different radionuclides.

Researchers discuss mechanism for overcoming resistance to drugs that target BRAF protein.

Increasing immune cell infiltration into tumors induces the immune system to block tumor growth.

Lipid from avocados targets leukemia stem cells.

Necitumumab added to chemotherapy increases survival to nearly a year.